More
Dr Zdenko Herceg, Head of the Epigenetics Group at the International Agency for Research on Cancer (IARC), answers questions about the EpiMark project and shares details of some exciting preliminary results, in a new interview to mark Breast Cancer Awareness Month, which occurs in October every year. The EpiMark project is a study of biomarkers in blood and their potential associations with breast cancer risk.
WHO Classification of Tumours: Head and Neck Tumours is now available in print format.
Head a...
The International Agency for Research on Cancer (IARC) is saddened by the passing of Professor JÃ...
The International Agency for Research on Cancer (IARC) is hosting the meeting of the Advisory Gro...